HIV-Related and Epstein–Barr Virus-Associated Anal Burkitt’s Lymphoma: Report of a Case
✍ Scribed by Sebastian Freudenberg; Pablo Palma; Rainer Grobholz; Louis Ngendahayo; Stefan Post
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 176 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0012-3706
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Epstein‐Barr virus (EBV) type 2 is considered to be a much less potent transformer of lymphocytes than type‐1. However, type‐2 EBV may be involved in the pathogenesis of non‐Hodgkin's lymphomas (NHLs) arising in immunocompromised patients, i.e., subjects with malaria or HIV‐1 infection.
## Abstract Tumour cell lines were established __in vitro__ from 16 cases of Epstein‐Barr (EB) virus genome‐positive Burkitt's lymphoma (BL), 7 of “endemic” origin (__i.e.__ from holoendemic malarial areas of Africa and of New Guinea) and 9 of “sporadic” origin (__i.e.__ from outside such high‐inci
## BACKGROUND. Epstein-Barr virus (EBV)-associated myogenic tumors in immunocompromised patients were recently recognized, but their biologic behavior remains only partially understood. Although observations so far have permitted the recognition of similarities between posttransplant myogenic tumo
Virus-associated hemophagocytic syndrome (VAHS) is a rare histiocytic proliferative disorder secondary to viral infection affecting children and young adults and in which there is both a poor prognosis and no specific treatment. We report a case of VAHS in a 22-year-old woman secondary to infection